In a decision with broad implications within and, potentially, outside the pharmaceutical industry, the Supreme Court has affirmed, by a 5-4 margin, the Ninth Circuit’s decision finding GlaxoSmithKline’s pharmaceutical sales representatives qualify for the outside sales exemption under the FLSA. Christopher v. SmithKline Beecham Corp., No. 11–204 (June 18, 2012). Justice Alito delivered
Court
New York’s Highest Court Addresses Liability for Bonuses
By Noel P. Tripp on
Posted in New York State
An unsettled fertile area of litigation in New York has been the circumstances under which various types of incentive compensation—such as bonuses—become “earned” as wages and thus entitled to the protections of the New York Labor Law, which provide greater remedies than common law claims for breach of contract. In a recent decision, New York’s…